Ovid Therapeutics Inc.OVIDNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank82
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.26
↑ 74% vs avg
Percentile
P82
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-0.99
Historical baseline
PeriodValueYoY Change
TTM-0.26+30.8%
2024-0.37+50.0%
2023-0.74+3.9%
2022-0.77-143.8%
20211.76+226.6%
2020-1.39+7.9%
2019-1.51+28.4%
2018-2.11+37.0%
2017-3.35-193.9%
2016-1.14-